Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.
New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for ...
Pain is registered in your body through nerve endings, which carry a signal to the brain. Journavx would prevent those pain-signaling nerves from firing in the first place. This is different from ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
The FDA has approved the first new type of pain medication in more than two decades — and it’s not an opioid. The drug is Suzetrigine under the brand name Journavx. It is now FDA-approved to treat ...
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...